IonQ Operating Cash Flow decreased by 102.7% to -$151.02M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 357.3%, from -$33.03M to -$151.02M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a 80.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$5.92M | -$12.03M | -$4.69M | -$8.32M | -$8.61M | -$12.86M | -$14.91M | -$13.82M | -$16.09M | -$22.28M | -$26.63M | -$20.47M | -$26.58M | -$19.21M | -$39.43M | -$33.03M | -$52.57M | -$123.08M | -$74.51M | -$151.02M |
| QoQ Change | — | -103.1% | +61.0% | -77.6% | -3.4% | -49.4% | -16.0% | +7.4% | -16.4% | -38.5% | -19.5% | +23.2% | -29.9% | +27.7% | -105.2% | +16.2% | -59.2% | -134.1% | +39.5% | -102.7% |
| YoY Change | — | — | — | — | -45.3% | -6.9% | -218.2% | -66.0% | -86.9% | -73.3% | -78.6% | -48.1% | -65.2% | +13.8% | -48.1% | -61.4% | -97.8% | -540.7% | -89.0% | -357.3% |